Cited by 220Gastrointestinal motility and disordersPsychosomatic Disorders and Their TreatmentsGastroesophageal reflux and treatments

The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.

Effect of Amitryptiline on Symptoms, Sleep, and Visceral Perception in Patients With Functional Dyspepsia

Mertz, H, Fass, R, Kodner, A, Yan-Go, F, Fullerton, S, Mayer, E A·1998·American Journal of Gastroenterology

Abstract

Objective Tricyclic antidepressants in low doses are widely used in the therapy of patients with functional gastrointestinal disorders, yet the mechanism(s) of action of these drugs in these disorders is not known. In the current study, we sought to determine in a group of patients with functional dyspepsia and associated poor sleep how amitryptiline affects digestive symptoms, perceptual responses to gastric distension, and subjective and objective measures of sleep. Methods Patients were randomized to 4 wk of amitryptiline 50 mg taken at bedtime versus placebo. There was a 3-wk washout phase, followed by a cross-over to the alternate treatment. Perceptual sensitivity to gastric distention and sleep EEG were recorded at the end of each treatment period. Diaries of symptoms were maintained throughout. Results Seven of seven patients reported significantly less severe gastrointestinal symptoms after 4 wk on amitryptiline compared to placebo. Five of seven patients had evidence for altered perception of gastric balloon distension during placebo. However, the subjective symptom improvement on amitryptiline was not associated with a normalization of the perceptual responses to gastric distension. Baseline sleep dysfunction in the form of reduced sleep efficiency, increased arousal, or abnormal amounts of REM sleep was found in all seven patients. Amitryptiline significantly reduced absolute and relative amounts of REM sleep, but had no effect on sleep parameters related to nonreg…

Overview

Integrity signals

Registry

Crossref · 10.1111/j.1572-0241.1998.00160.x

Cites

2 of 2 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Amitriptyline (50mg) was associated with poorer sleep efficiency for patients with functional dyspepsia, compared to placebo.

    “In another study (Mertz et al., 1998), amitriptyline (50mg) was associated with poorer sleep efficiency for patients with functional dyspepsia, compared to placebo.”

    From Antidepressants and their effect on sleep (2005) · cites this paper as Mertz et al., 1998

  • Amitriptyline (50mg) reduced REM sleep in gastroenterology patients, compared to placebo.

    “(Mertz et al., 1998) found that amitriptyline (50mg) reduced REM sleep in gastroenterology patients, compared to placebo, while (Carette et al., 1995) demonstrated fewer changes in REM sleep parameters in fibromyalgia patients (dosage, 25mg).”

    From Antidepressants and their effect on sleep (2005) · cites this paper as Mertz et al., 1998

Citations

Cites

Flagged first, then by citations

Research works printed but not linked: 31

  1. Talley NJ, 1988, Ann Intern Med, 108, 865, 10.7326/0003-4819-108-6-865 · DOI
  2. Malagelada JR, 1993, Basic and clinical aspects of chronic abdominal pain, 55
  3. Bradette M, 1991, Dig Dis Sci, 36, 52, 10.1007/BF01300087 · DOI
  4. Mertz H, 1996, Gut
  5. Agreus L, 1995, Gastroenterology, 109, 671, 10.1016/0016-5085(95)90373-9 · DOI · Paper page
  6. Fass R, 1995, Gastroenterology, 108, A596
  7. David D, 1994, Gut, 35, 916, 10.1136/gut.35.7.916 · DOI
  8. Klein KB, 1988, Gastroenterology, 95, 232, 10.1016/0016-5085(88)90319-8 · DOI
  9. Greenbaum DS, 1987, Dig Dis Sci, 32, 257, 10.1007/BF01297051 · DOI
  10. 10.1056/NEJM199405193302003 · DOI
  11. Myren J, 1984, Scand J Gastroenterol, 19, 835, 10.1080/00365521.1984.12005817 · DOI
  12. Clouse RE, 1994, Dig Dis Sci, 39, 2352, 10.1007/BF02087651 · DOI
  13. Max MB, 1992, N Engl J Med, 326, 1250, 10.1056/NEJM199205073261904 · DOI
  14. 10.1016/0304-3959(92)90144-Z · DOI
  15. Silverman DHS, 1996, Gastroenterology, 110, A759
  16. 10.1016/S0140-6736(94)92755-3 · DOI
  17. 10.1016/0304-3959(95)00048-W · DOI
  18. Moldofsky H, 1976, Psychosom Med, 38, 35, 10.1097/00006842-197601000-00006 · DOI
  19. 10.1016/0304-3959(91)90047-2 · DOI
  20. Antidepressants Richelson E., 1990, Mayo Clin Proc, 65, 1227, 10.1016/S0025-6196(12)62747-5 · DOI
  21. Talley NJ, 1990, Mayo Clin Proc, 65, 1456, 10.1016/S0025-6196(12)62169-7 · DOI · Paper page
  22. Mertz H, 1995, Gastroenterology, 109, 40, 10.1016/0016-5085(95)90267-8 · DOI
  23. American Sleep Disorders Association, 1992, Sleep, 15, 174, 10.1093/sleep/15.2.174 · DOI
  24. Mertz H, 1995, Neurogastroenterol Motil, 7, 175, 10.1111/j.1365-2982.1995.tb00223.x · DOI
  25. Moldofsky H, 1989, Rheumat Dis Clin North Am, 15, 91, 10.1016/S0889-857X(21)00035-1 · DOI
  26. Moldofsky H, 1993, Basic and clinical aspects of chronic abdominal pain
  27. Goldsmith G, 1993, Dig Dis Sci, 38, 1809, 10.1007/BF01296103 · DOI
  28. Kumar D, 1992, Gastroenterology, 103, 12, 10.1016/0016-5085(92)91089-M · DOI
  29. 10.1016/0165-0173(88)90007-0 · DOI
  30. Reichling DB, 1988, Aratomy, physiology and pharmacology of the periaqueductal gray contribution to antinociceptive controls
  31. 10.1016/0304-3959(94)00142-2 · DOI

Cited by

Sorted by citations

Metadata

Authors
Mertz, H., Fass, R., Kodner, A., Yan-Go, F., Fullerton, S., & Mayer, E. A.
Affiliations
University of California, Los Angeles (US)
Corresponding author
Mertz, H
Venue
American Journal of Gastroenterology
Published
1998-02
Volume
93
Issue
2
Pages
160-165
ISSN
0002-9270 (ISSN-L)
OpenAlex
W1975230079
Cited by
220
References
2
Citations by year
2026: 2 · 2025: 4 · 2024: 3 · 2023: 4 · 2022: 3 · 2021: 4 · 2020: 4 · 2019: 1 · 2018: 2 · 2017: 5 · 2016: 2 · 2015: 9 · 2014: 10 · 2013: 11 · 2012: 10
FWCI
8.81
Type
journal article
Language
en
Open access
closed
Locations
  • The American Journal of Gastroenterology (publishedVersion)
  • PubMed (publishedVersion)
Funders
National Institute of Diabetes and Digestive and Kidney Diseases (R01DK040919, P30DK041301)
Topics
  • Health Sciences › Medicine › Gastroenterology › Gastrointestinal motility and disorders
  • Health Sciences › Medicine › Psychiatry and Mental health › Psychosomatic Disorders and Their Treatments
  • Health Sciences › Medicine › Gastroenterology › Gastroesophageal reflux and treatments
Keywords
amitriptyline, functional dyspepsia, tricyclic antidepressants, sleep, REM sleep, gastric distension, visceral sensation, visceral sensitivity, sleep efficiency, arousal, gastrointestinal symptoms, functional gastrointestinal disorders
MeSH terms
Adult, Aged, Amitriptyline, Antidepressive Agents, Tricyclic, Dilatation, Double-Blind Method, Dyspepsia, Female, Humans, Male, Middle Aged, Perception, Sleep, Stomach

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review